Comparable Fusion Response, but Increased Inflammatory Response, with Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Posterior Lumbar Interbody Fusion Surgery
Journal of Clinical Medicine · 22.05.2026 · 15 (11) · 4026
DOI: 10.3390/jcm15114026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 22.05.2026. Verfasst von Mu Ha Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This retrospective study aimed to evaluate the radiologic outcomes and changes in biochemical inflammatory markers following posterior lumbar interbody fusion (PLIF) with Escherichia coli-derived recombinant human bone morphogenetic protein-2 (E.BMP-2), compared with conventional autologous bone grafting.
Methods
The study included 112 patients undergoing single- or two-level PLIF for degenerative lumbar disease between 2022 and 2023, divided into E.BMP-2 (n = 50) and Control (n = 62) groups. Radiological outcomes, including Bridwell grading system and adjacent vertebral body (VB) changes, and changes in biochemical inflammatory markers—white blood cell (WBC) count, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and neutrophil count—were assessed. Clinical outcomes were also evaluated. Multivariate regression and propensity-score-matched analyses, and linear mixed-effects models were applied.
Results
Fusion rates were comparable between the groups (90.8% vs. 96.7%; p = 0.466); adjusted analyses showed no independent association between E.BMP-2 use and fusion outcomes. The E.BMP-2 group demonstrated a higher prevalence of adjacent VB changes (78.5% vs. 54.3%; p = 0.001), and higher postoperative inflammatory markers including CRP levels on postoperative day 7 and at 1 month, along with increased neutrophil levels on postoperative day 4 (CRP day 7: 31.7 ± 26.4 mg/L vs. 18.7 ± 14.4 mg/L, p = 0.014; CRP 1 month: 7.2 ± 13.0 mg/L vs. 2.7 ± 3.8 mg/L, p = 0.022; neutrophil count day 4: 64.4 ± 10.6% vs. 60.6 ± 8.7%, p = 0.039). However, no significant differences in clinical outcomes, as assessed by VAS scores, were observed according to adjacent VB changes or inflammatory markers. Postoperative fever and infection rates were similar between groups.
Conclusions
E.BMP-2 use in PLIF demonstrated fusion rates comparable to those of autografts, without demonstrated superiority. No significant differences in clinical outcomes were identified. Further large-scale prospective studies are needed to clarify its clinical role and optimal dosing.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Soonchunhyang University Seoul Hospital, Seoul 04401, Republic of Korea.
- Department of Neurosurgery, Spine and Spinal Cord Institute, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea.
- Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Republic of Korea.
ORCID-Profile: Mu Ha Lee, Keun Su Kim, Jae Keun Oh, Bong Ju Moon
Zitieren
APA
Lee, M. H., Jang, H. J., Kim, K. H., Park, J. Y., Kuh, S. U., Chin, D. K., Kim, K. S., Oh, J. K., & Moon, B. J. (2026). Comparable Fusion Response, but Increased Inflammatory Response, with Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Posterior Lumbar Interbody Fusion Surgery. Journal of Clinical Medicine, 15(11), 4026. https://doi.org/10.3390/jcm15114026
Vancouver
Lee MH, Jang HJ, Kim KH, Park JY, Kuh SU, Chin DK, et al. Comparable Fusion Response, but Increased Inflammatory Response, with Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Posterior Lumbar Interbody Fusion Surgery. Journal of Clinical Medicine. 2026;15(11):4026. doi:10.3390/jcm15114026
BibTeX
@article{Lee2026,
author = {Lee, Mu Ha and Jang, Hyun Jun and Kim, Kyung Hyun and Park, Jeong-Yoon and Kuh, Sung Uk and Chin, Dong Kyu and Kim, Keun Su and Oh, Jae Keun and Moon, Bong Ju},
title = {Comparable Fusion Response, but Increased Inflammatory Response, with Escherichia coli-Derived Recombinant Human Bone Morphogenetic Protein-2 in Posterior Lumbar Interbody Fusion Surgery},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4026},
doi = {10.3390/jcm15114026}
}
EUVIMED